SEGMENT REPORTING (Tables)

12 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

SCHEDULE OF SEGMENT INFORMATION

Certain information concerning the Company’s segments is presented in the following tables (in thousands):

	For the Year Ended December 31,
	2021			2020
Net revenues:
Reportable segments:
Regenerative medicine products	$	3,076		$	3,730
Contract services		6,328			6,396
Total net revenues	$	9,404		$	10,126
Net income/(loss):
Reportable segments:
Regenerative medicine products	$	(29,568	)	$	(42,815	)
Contract services		(619	)		(39	)
Total net loss	$	(30,187	)	$	(42,854	)

	December 31, 2021		December 31, 2020
Identifiable assets employed:
Reportable segments:
Regenerative medicine products	$	25,344	$	36,858
Contract services		5,834		8,652
Total assets	$	31,178	$	45,510